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In the title compound, C12H14N2O, the imidazole ring forms a
dihedral angle of 66.73 (5)  with the phenyl ring. In the crystal,
molecules are linked via O—H   Na n dC — H    O hydrogen
bonds into sheets lying parallel to (100). The crystal structure
is further consolidated by C—H     interactions.
Related literature
For general background to and the pharmacological activities
of the title compound, see: Latge (1999); Steenbergn &
Casadevall (2000); Pacetti & Gelone (2003); Spellberg et al.
(2006). For the preparation of the title compound, see: Aboul-
Enein et al. (2011). For the stability of the temperature







a = 9.0352 (5) A ˚
b = 11.8521 (7) A ˚
c = 10.3462 (6) A ˚
  = 109.688 (1) 
V = 1043.17 (10) A ˚ 3
Z =4
Mo K  radiation
  = 0.08 mm
 1
T = 100 K
0.34   0.26   0.19 mm
Data collection




Tmin = 0.972, Tmax = 0.985
14426 measured reﬂections
3777 independent reﬂections











H atoms treated by a mixture of
independent and constrained
reﬁnement
 max = 0.67 e A ˚  3
 min =  0.26 e A ˚  3
Table 1
Hydrogen-bond geometry (A ˚ ,  ).
Cg1 is the centroid of the C1–C6 phenyl ring.
D—H   AD —H H   AD    AD —H   A
O1—H1O1   N2
i 0.964 (19) 1.89 (2) 2.8432 (12) 171.7 (17)
C1—H1B   O1
ii 0.95 2.48 3.4188 (12) 172
C10—H10A   Cg1
iii 0.95 2.68 3.4778 (12) 142
C12—H12A   Cg1
iv 0.95 2.69 3.5373 (11) 149
Symmetry codes: (i)  x þ 1;y   1
2; z þ 1
2; (ii)  x þ 1; y; z þ 1; (iii)
 x þ 1;y þ 1
2; z þ 1
2; (iv)  x;y þ 1
2; z þ 1
2.
Data collection: APEX2 (Bruker, 2009); cell reﬁnement: SAINT
(Bruker, 2009); data reduction: SAINT; program(s) used to solve
structure: SHELXTL (Sheldrick, 2008); program(s) used to reﬁne
structure: SHELXTL; molecular graphics: SHELXTL; software used
to prepare material for publication: SHELXTL and PLATON (Spek,
2009).
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Supplementary data and ﬁgures for this paper are available from the
IUCr electronic archives (Reference: HB6620).
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3-(1H-Imidazol-1-yl)-1-phenylpropan-1-ol
Hoong-Kun Fun, Ching Kheng Quah, Mohamed I. Attia, Hatem A. Abdel-Aziz and Khalid A. Al-
Rashood
Comment 
Over the past three decades, the incidence of both community-acquired and nosocomial invasive fungal infections has 
increased substantially. Clinically, candidosis, aspergillosis and cryptococcosis have been identified as three major 
opportunistic pathogens in the etiology of fungal infections in immune compromised patients (Latge, 1999; Steenbergn & 
Casadevall, 2000). Candida albicans accounts for the majority of invasive and superficial Candida infections (Pacetti & 
Gelone, 2003; Spellberg et al., 2006). Accordingly, the need for new antifungal drugs has prompted intensive research 
worldwide. The azole antifungal drugs constitute one of the major classes which are characterized by having the azole 
pharmacophoric moiety embedded in their structures. The title molecule exhibited anti-Candida activity (MIC = 10 
µg/ml) and can serve as a prototypic molecule for subsequent molecular modifications.
In the title compound, Fig. 1, the imidazole ring (N1/N2/C10–C12, maximum deviation of 0.002 (1) Å at atoms N1 and 
C12) forms a dihedral angle of 66.73 (5)° with the phenyl ring (C1–C6).
In the crystal structure, Fig. 2, molecules are linked via intermolecular O1—H1O1···N2 and C1—H1B···O1 hydrogen 
bonds (Table 1) into two-dimensional networks parallel to (100). The crystal structure is further consolidated by C10—
H10A···Cg1iii and C12—H12A···Cg1iv (Table 1) interactions, where Cg1 is the centroid of C1–C6 phenyl ring.
Experimental 
NaBH4 (4.9 g, 0.13 mol) was added portion-wise to an ice cooled, stirred solution of 3-(1H-imidazol-1-yl)-1-phenyl-
propan-1-one (8.6 g, 0.043 mol) (Aboul-Enein et al., 2011) in methanol (100 ml). The mixture was stirred overnight at 
ambient temperature followed by evaporation of methanol under vacuum. The residue was dissolved in ethyl acetate (150 
ml) and washed with water (3 × 50 ml). The organic layer was separated, dried (Na2SO4) and evaporated under reduced 
pressure. The residue was recrystallized from ethanol to give the title compound as colourless blocks. M.p. = 380–382 K.
Refinement 
Atom H1O1 was located in a difference Fourier map and refined freely with O1—H1O1 = 0.97 (2) Å. The remaining H 
atoms were positioned geometrically and refined using a riding model with C—H = 0.95 or 0.99 Å and Uiso(H) = 
1.2Ueq(C).
Computing details 
Data collection: APEX2 (Bruker, 2009); cell refinement: SAINT (Bruker, 2009); data reduction: SAINT (Bruker, 2009); 
program(s) used to solve structure: SHELXTL (Sheldrick, 2008); program(s) used to refine structure: SHELXTL 
(Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare material for publication: 
SHELXTL (Sheldrick, 2008) and PLATON (Spek, 2009).supplementary materials
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Figure 1
The molecular structure of the title compound showing 50% probability displacement ellipsoids for non-H atoms. 
Figure 2
The crystal structure of the title compound, viewed along the c axis. H atoms not involved in hydrogen bonds (dashed 






Hall symbol: -P 2ybc
a = 9.0352 (5) Å
b = 11.8521 (7) Å
c = 10.3462 (6) Å
β = 109.688 (1)°
V = 1043.17 (10) Å3
Z = 4
F(000) = 432
Dx = 1.288 Mg m−3
Mo Kα radiation, λ = 0.71073 Å
Cell parameters from 6547 reflections
θ = 3.0–32.6°
µ = 0.08 mm−1
T = 100 K
Block, colourless
0.34 × 0.26 × 0.19 mmsupplementary materials
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Data collection 
Bruker SMART APEXII DUO CCD 
diffractometer
Radiation source: fine-focus sealed tube
Graphite monochromator
φ and ω scans
Absorption correction: multi-scan 
(SADABS; Bruker, 2009)
Tmin = 0.972, Tmax = 0.985
14426 measured reflections
3777 independent reflections
3245 reflections with I > 2σ(I)
Rint = 0.022













Primary atom site location: structure-invariant 
direct methods
Secondary atom site location: difference Fourier 
map
Hydrogen site location: inferred from 
neighbouring sites
H atoms treated by a mixture of independent 
and constrained refinement
w = 1/[σ2(Fo
2) + (0.0644P)2 + 0.3608P] 




Δρmax = 0.67 e Å−3
Δρmin = −0.26 e Å−3
Special details 
Experimental. The crystal was placed in the cold stream of an Oxford Cryosystems Cobra open-flow nitrogen cryostat 
(Cosier & Glazer, 1986) operating at 100.0 (1) K.
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance 
matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; 
correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate 
(isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, 
conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2sigma(F2) is 
used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based 
on F2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
xyzU iso*/Ueq
O1 0.48286 (8) 0.08562 (6) 0.36457 (8) 0.02067 (16)
N1 0.25481 (8) 0.31589 (7) 0.35682 (8) 0.01420 (15)
N2 0.32358 (10) 0.45590 (7) 0.24613 (9) 0.02066 (17)
C1 0.31643 (10) −0.13411 (8) 0.29554 (9) 0.01560 (16)
H1B 0.3689 −0.1285 0.3918 0.019*
C2 0.27877 (11) −0.23971 (8) 0.23471 (10) 0.01808 (18)
H2B 0.3073 −0.3059 0.2892 0.022*
C3 0.19909 (12) −0.24865 (8) 0.09354 (10) 0.01975 (18)
H3A 0.1735 −0.3208 0.0519 0.024*
C4 0.15757 (11) −0.15146 (9) 0.01470 (9) 0.01935 (18)
H4A 0.1013 −0.1570 −0.0809 0.023*
C5 0.19809 (11) −0.04577 (8) 0.07534 (9) 0.01624 (17)
H5A 0.1713 0.0203 0.0203 0.019*
C6 0.27760 (10) −0.03610 (8) 0.21592 (9) 0.01380 (16)supplementary materials
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C7 0.32242 (10) 0.07925 (8) 0.28116 (9) 0.01549 (16)
H7A 0.3017 0.1370 0.2066 0.019*
C8 0.22380 (10) 0.10796 (8) 0.37099 (9) 0.01587 (16)
H8A 0.1118 0.1116 0.3124 0.019*
H8B 0.2350 0.0464 0.4383 0.019*
C9 0.26905 (11) 0.21929 (8) 0.44836 (9) 0.01656 (17)
H9A 0.2007 0.2317 0.5044 0.020*
H9B 0.3789 0.2142 0.5117 0.020*
C10 0.37482 (11) 0.37408 (8) 0.33713 (10) 0.01860 (18)
H10A 0.4828 0.3579 0.3833 0.022*
C11 0.16177 (11) 0.44949 (8) 0.20509 (10) 0.01811 (18)
H11A 0.0914 0.4980 0.1397 0.022*
C12 0.11734 (10) 0.36343 (8) 0.27205 (9) 0.01602 (17)
H12A 0.0131 0.3411 0.2621 0.019*
H1O1 0.543 (2) 0.0448 (17) 0.3186 (19) 0.048 (5)*
Atomic displacement parameters (Å2) 
U11 U22 U33 U12 U13 U23
O1 0.0152 (3) 0.0220 (4) 0.0251 (3) −0.0023 (2) 0.0071 (3) −0.0072 (3)
N1 0.0142 (3) 0.0116 (3) 0.0184 (3) 0.0000 (2) 0.0076 (3) −0.0010 (2)
N2 0.0182 (3) 0.0179 (4) 0.0290 (4) 0.0007 (3) 0.0120 (3) 0.0036 (3)
C1 0.0146 (3) 0.0167 (4) 0.0159 (3) 0.0024 (3) 0.0057 (3) 0.0012 (3)
C2 0.0204 (4) 0.0137 (4) 0.0232 (4) 0.0028 (3) 0.0114 (3) 0.0018 (3)
C3 0.0227 (4) 0.0154 (4) 0.0244 (4) −0.0015 (3) 0.0121 (3) −0.0055 (3)
C4 0.0207 (4) 0.0212 (4) 0.0160 (4) −0.0009 (3) 0.0060 (3) −0.0035 (3)
C5 0.0174 (4) 0.0158 (4) 0.0159 (4) 0.0010 (3) 0.0062 (3) 0.0007 (3)
C6 0.0125 (3) 0.0141 (4) 0.0160 (3) −0.0003 (3) 0.0063 (3) −0.0015 (3)
C7 0.0155 (3) 0.0142 (4) 0.0180 (4) −0.0009 (3) 0.0072 (3) −0.0011 (3)
C8 0.0176 (4) 0.0127 (4) 0.0205 (4) −0.0004 (3) 0.0106 (3) −0.0001 (3)
C9 0.0207 (4) 0.0135 (4) 0.0176 (4) 0.0012 (3) 0.0091 (3) 0.0003 (3)
C10 0.0141 (4) 0.0174 (4) 0.0262 (4) −0.0003 (3) 0.0092 (3) 0.0014 (3)
C11 0.0176 (4) 0.0168 (4) 0.0219 (4) 0.0032 (3) 0.0092 (3) 0.0020 (3)
C12 0.0136 (3) 0.0160 (4) 0.0195 (4) 0.0003 (3) 0.0069 (3) −0.0012 (3)
Geometric parameters (Å, º) 
O1—C7 1.4173 (11) C4—H4A 0.9500
O1—H1O1 0.97 (2) C5—C6 1.3931 (12)
N1—C10 1.3571 (11) C5—H5A 0.9500
N1—C12 1.3767 (11) C6—C7 1.5180 (12)
N1—C9 1.4636 (12) C7—C8 1.5269 (12)
N2—C10 1.3218 (13) C7—H7A 1.0000
N2—C11 1.3802 (12) C8—C9 1.5260 (13)
C1—C2 1.3907 (13) C8—H8A 0.9900
C1—C6 1.3986 (12) C8—H8B 0.9900
C1—H1B 0.9500 C9—H9A 0.9900
C2—C3 1.3979 (14) C9—H9B 0.9900
C2—H2B 0.9500 C10—H10A 0.9500
C3—C4 1.3881 (14) C11—C12 1.3671 (13)supplementary materials
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C3—H3A 0.9500 C11—H11A 0.9500
C4—C5 1.3936 (13) C12—H12A 0.9500
C7—O1—H1O1 107.8 (11) C6—C7—C8 110.39 (7)
C10—N1—C12 106.94 (8) O1—C7—H7A 108.7
C10—N1—C9 126.45 (8) C6—C7—H7A 108.7
C12—N1—C9 126.60 (7) C8—C7—H7A 108.7
C10—N2—C11 105.03 (8) C9—C8—C7 113.82 (7)
C2—C1—C6 120.42 (8) C9—C8—H8A 108.8
C2—C1—H1B 119.8 C7—C8—H8A 108.8
C6—C1—H1B 119.8 C9—C8—H8B 108.8
C1—C2—C3 120.16 (9) C7—C8—H8B 108.8
C1—C2—H2B 119.9 H8A—C8—H8B 107.7
C3—C2—H2B 119.9 N1—C9—C8 112.79 (7)
C4—C3—C2 119.55 (9) N1—C9—H9A 109.0
C4—C3—H3A 120.2 C8—C9—H9A 109.0
C2—C3—H3A 120.2 N1—C9—H9B 109.0
C3—C4—C5 120.22 (8) C8—C9—H9B 109.0
C3—C4—H4A 119.9 H9A—C9—H9B 107.8
C5—C4—H4A 119.9 N2—C10—N1 111.96 (8)
C6—C5—C4 120.59 (8) N2—C10—H10A 124.0
C6—C5—H5A 119.7 N1—C10—H10A 124.0
C4—C5—H5A 119.7 C12—C11—N2 110.28 (8)
C5—C6—C1 119.04 (8) C12—C11—H11A 124.9
C5—C6—C7 120.32 (8) N2—C11—H11A 124.9
C1—C6—C7 120.64 (8) C11—C12—N1 105.80 (8)
O1—C7—C6 112.55 (7) C11—C12—H12A 127.1
O1—C7—C8 107.72 (7) N1—C12—H12A 127.1
C6—C1—C2—C3 −1.16 (13) O1—C7—C8—C9 52.81 (10)
C1—C2—C3—C4 −0.15 (14) C6—C7—C8—C9 176.07 (7)
C2—C3—C4—C5 1.41 (14) C10—N1—C9—C8 −107.01 (10)
C3—C4—C5—C6 −1.37 (14) C12—N1—C9—C8 71.41 (11)
C4—C5—C6—C1 0.06 (13) C7—C8—C9—N1 59.04 (10)
C4—C5—C6—C7 179.56 (8) C11—N2—C10—N1 −0.15 (11)
C2—C1—C6—C5 1.20 (12) C12—N1—C10—N2 0.31 (11)
C2—C1—C6—C7 −178.30 (8) C9—N1—C10—N2 178.99 (8)
C5—C6—C7—O1 −129.62 (8) C10—N2—C11—C12 −0.07 (11)
C1—C6—C7—O1 49.88 (10) N2—C11—C12—N1 0.25 (11)
C5—C6—C7—C8 109.98 (9) C10—N1—C12—C11 −0.33 (10)
C1—C6—C7—C8 −70.52 (10) C9—N1—C12—C11 −179.01 (8)
Hydrogen-bond geometry (Å, º) 
Cg1 is the centroid of the C1–C6 phenyl ring.
D—H···AD —H H···AD ···AD —H···A
O1—H1O1···N2i 0.964 (19) 1.89 (2) 2.8432 (12) 171.7 (17)
C1—H1B···O1ii 0.95 2.48 3.4188 (12) 172supplementary materials
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C10—H10A···Cg1iii 0.95 2.68 3.4778 (12) 142
C12—H12A···Cg1iv 0.95 2.69 3.5373 (11) 149
Symmetry codes: (i) −x+1, y−1/2, −z+1/2; (ii) −x+1, −y, −z+1; (iii) −x+1, y+1/2, −z+1/2; (iv) −x, y+1/2, −z+1/2.